MARK2 and neoplasm: Activation of well-known downstream cascades like the MAP kinases or phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT serine/threonine kinase (AKT) finally leads to enhanced tumor cell survival, inhibition of apoptotic signaling, or enhanced metastasis (10, 39).